Science Explorer Back to mapMap
Discussion
Nonprofit · Alcobendas · Spain

Venter Pharma (Spain)

venterpharma.comROR OpenAlex
Research works
3
▲ 93% vs 2018-21
Citations
20
5.8 per fractional work
Top-10% rate
1.4%
all institutions 10.0%
Open access
52%
world 40%
International
2%
world 18%
Venter Pharma (Spain)

Not ranked overall: Venter Pharma (Spain) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Venter Pharma (Spain) work in?

In all years, 48% of research at Venter Pharma (Spain) is in Health Sciences, 39% in Life Sciences. Its largest fields are Medicine (36%), Biochemistry, Genetics and Molecular Biology (33%), Nursing (12%).

Health Sciences: 2 fractional works · 48.5% of its workMedicine: 1 fractional works · 36.4% of its workNursing: 0 fractional works · 12.1% of its workLife Sciences: 1 fractional works · 39.4% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 33.3% of its workAgricultural and Biological Sciences: 0 fractional works · 3.0% of its workNeuroscience: 0 fractional works · 3.0% of its workPhysical Sciences: 0 fractional works · 9.1% of its workEngineering: 0 fractional works · 9.1% of its workSocial Sciences: 0 fractional works · 3.0% of its workSocial Sciences: 0 fractional works · 3.0% of its workALL ITS WORKVenter Pharma(Spain)3fractional works, all years
Life Sciences39%Physical Sciences9%Health Sciences48%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 7 fields, with their numbers
    1. Medicine136.4%
    2. Nursing012.1%
    1. Biochemistry, Genetics and Molecular Biology133.3%
    2. Agricultural and Biological Sciences03.0%
    3. Neuroscience03.0%
    1. Engineering09.1%
    1. Social Sciences03.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Venter Pharma (Spain)?

The most cited paper from Venter Pharma (Spain) is "Noninvasive Diagnosis of Hypolactasia With 4-Galactosylxylose (Gaxilose)" (Juan J. Aragón, Carmen Hermida, Óscar H. Martínez-Costa et al., 2013), with 30 citations. Next come "Conditional deletion of Rcan1 predisposes to hypertension-mediated intramural hematoma and subsequent aneurysm and aortic rupture" (18) and "Phase I and Phase IB Clinical Trials for the Noninvasive Evaluation of Intestinal Lactase With 4-Galactosylxylose (Gaxilose)" (17).

Most cited papers
#PaperReleasedCitations
1 Noninvasive Diagnosis of Hypolactasia With 4-Galactosylxylose (Gaxilose) Juan J. Aragón, Carmen Hermida, Óscar H. Martínez-Costa et al. · Journal of Clinical Gastroenterology 30 May 2013 30
2 Conditional deletion of Rcan1 predisposes to hypertension-mediated intramural hematoma and subsequent aneurysm and aortic rupture Silvia Villahoz, Paula Sofía Yunes-Leites, Nerea Méndez‐Barbero et al. · Nature Communications Open access 9 Nov 2018 18
3 Phase I and Phase IB Clinical Trials for the Noninvasive Evaluation of Intestinal Lactase With 4-Galactosylxylose (Gaxilose) Carmen Hermida, Pedro Ignacio Cardona Guerra, Óscar H. Martínez-Costa et al. · Journal of Clinical Gastroenterology 15 Jan 2013 17
4 Improvement and Validation of d ‐Xylose Determination in Urine and Serum as a New Tool for the Noninvasive Evaluation of Lactase Activity in Humans Carmen Hermida, Óscar H. Martínez-Costa, Guillermo Moreno Corrales et al. · Journal of Clinical Laboratory Analysis Open access 22 Mar 2014 11
5 Phase IV noninferiority controlled randomized trial to evaluate the impact on diagnostic thinking and patient management and the test–retest reproducibility of the Gaxilose test for hypolactasia diagnosis Carmen Monsalve-Hernando, Laura Varela Crespo, Blanca Ferreiro et al. · Medicine Open access Nov 2018 9
All 11 most cited papers, with filters and sorting

Which research topics does Venter Pharma (Spain) publish most on?

By volume in 2022-now: Gastrointestinal motility and disorders, Biochemical Analysis and Sensing Techniques, Digestive system and related health and Entomological Studies and Ecology.

Gastrointestinal motilit…0Gastrointestinal motility and disorders: 0 fractional worksBiochemical Analysis and…0Biochemical Analysis and Sensing Techniques: 0 fractional worksDigestive system and rel…0Digestive system and related health: 0 fractional worksEntomological Studies and Ecology: 0 fractional worksSympathectomy and Hyperhidrosis Treatments: 0 fractional worksAllergic Rhinitis and Se…0Allergic Rhinitis and Sensitization: 0 fractional works
GastroenterologyNutrition and DieteticsGeneticsEcology, Evolution, Behavior and Systematics2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Gastrointestinal motility and disorders Gastroenterology 0 works
  2. 2 Biochemical Analysis and Sensing Techniques Nutrition and Dietetics 0 works
  3. 3 Digestive system and related health Genetics 0 works
  4. 4 Entomological Studies and Ecology Ecology, Evolution, Behavior and Systematics 0 works
  5. 5 Sympathectomy and Hyperhidrosis Treatments Physiology 0 works
  6. 6 Allergic Rhinitis and Sensitization Immunology and Allergy 0 works
  7. 7 Olfactory and Sensory Function Studies Sensory Systems 0 works
  8. 8 Vestibular and auditory disorders Neurology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.8%not open48.2%

World: 40% of research is openly available.

with international co-authors2.2%domestic only97.8%

World: 18% is written across borders.

How has Venter Pharma (Spain)'s research output changed?

Output in 2022-2025 was 93% higher than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Alcobendas

All research institutions in Alcobendas

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Venter Pharma (Spain). Posts are plain text and can be reported.